Cargando…

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?

Detalles Bibliográficos
Autores principales:	Crane, Harry, Danta, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170279/ https://www.ncbi.nlm.nih.gov/pubmed/37181340 http://dx.doi.org/10.21037/atm-23-205

Ejemplares similares

Uncovering the mechanism of action of aspirin in HCC chemoprevention
por: Roehlen, Natascha, et al.
Publicado: (2019)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

May an aspirin a day truly take hepatocellular carcinoma away?
por: Giannini, Edoardo G., et al.
Publicado: (2023)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
por: Zhang, Ping, et al.
Publicado: (2018)

The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
por: Zhang, Zeyu, et al.
Publicado: (2019)

Surveillance of hepatocellular carcinoma: is only ultrasound enough?
por: Jeong, Woo Kyoung
Publicado: (2017)

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
por: Zeng, Georgia, et al.
Publicado: (2020)

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma
por: Zhou, Jiyuan, et al.
Publicado: (2019)

Peripheral Neuropathy in Children with Chronic Kidney Disease: Are we Looking Enough? An Editorial
por: Viswanathan, Shanthi
Publicado: (2022)

Indictment by Association: Once Is Not Enough
por: Pellett, Philip E.
Publicado: (2015)

The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis
por: Liu, Min, et al.
Publicado: (2023)

In-house Stroke: Are We Concerned Enough?
por: Chakraborty, Debabrata
Publicado: (2023)

Metal Exposure and Stroke: Are We Concerned Enough?
por: Chakraborty, Debabrata
Publicado: (2022)

Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016)

Enough is enough
por: Borowski, Christine
Publicado: (2011)

Hepatic encephalopathy: Ever closer to its big bang
por: Souto, Pablo A, et al.
Publicado: (2016)

Cardioneuroablation for treating functional bradyarrhythmias. How much is enough?
por: Pachon-M, J.C., et al.
Publicado: (2021)

Comparison between using hepatocellular carcinoma (HCC) risk scores and the HCC national guideline to identify high‐risk chronic hepatitis B patients for HCC surveillance in Thailand
por: Rattananukrom, Chitchai, et al.
Publicado: (2022)

Hepatitis B—More Treatments, More Testing, Not Enough Data
por: Fox, Rena K.
Publicado: (2011)

Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
por: Negri, Francesca, et al.
Publicado: (2021)

What Ever Happened to the Scientific Conversation?
por: Goldenring, James R.
Publicado: (2016)

Will we ever eradicate animal tuberculosis?
por: Gortázar, Christian, et al.
Publicado: (2023)

Oxygen “therapy” for infection in liver transplant surgery: less is more, enough is enough
por: Ho, Cheng-Maw, et al.
Publicado: (2023)

Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012)

Non-targeted biopsies in hereditary diffuse gastric cancer: Necessary, but not enough
por: Buckley, Kole H., et al.
Publicado: (2023)

Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy
por: Wang, Yun, et al.
Publicado: (2016)

Ever-changing homes
por: Duarte, Delfim
Publicado: (2018)

As Funny as Ever
Publicado: (1867)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

Octogenarians in the ICU: are you ever too old?
por: McDermid, Robert C, et al.
Publicado: (2011)

Finding a cure for HIV: will it ever be achievable?
por: Lewin, Sharon R, et al.
Publicado: (2011)

Retained placenta: will medical treatment ever be possible?
por: Akol, Achier D., et al.
Publicado: (2016)

When one cell is enough
por: Ceredig, Rhodri
Publicado: (2012)

Is enough oxygen too much?
por: Schumacker, Paul T
Publicado: (2010)

Magnesium: Are We Consuming Enough?
por: Razzaque, Mohammed S.
Publicado: (2018)

Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c5hv1sr5ru70tt1in0buru3nmn